Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced clinical data indicating zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC), provides rapid and ...
U.S. FDA accepts and grants Priority Review for the Biologics License Application for ifinatamab deruxtecan. The application ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...
What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns ...
Nuvation Bio Inc. (NYSE:NUVB) is one of the best stock picks of billionaire David Abrams. Nuvation Bio Inc. (NYSE:NUVB) is ...
A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.
Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University ...
Revolution Medicines announced that its investigational RAS inhibitor daraxonrasib doubled median overall survival for ...
The update comes just four days after Vitale first went public with the news that biopsy results had confirmed melanoma in ...
Six poster presentations showcase Zymeworks' next-generation ADC programs, including multiple first-in-class pan-RAS inhibitor ADCs Data highlight efficacy, tumor-selective delivery, and favorable tol ...
Regeneron and Telix announced a strategic radiopharma collaboration worth up to $4.3 billion. Daiichi Sankyo entered a $1.55 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results